<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "LORazepam tab SL">
<dose><value>0.5</value>
<value>0.5 - 1</value>
<value>1</value>
<value>2</value>
</dose><route><value>PO</value>
<value>PO/SL</value>
<value>SL</value>
</route><form><value>tab SL</value>
</form><drugname><value>LORazepam tab SL</value>
</drugname><strength><value>0.5 mg</value>
<value>1 mg</value>
<value>2 mg</value>
</strength><frequency><value>BID</value>
<value>TID</value>
<value>HS</value>
<value>QID</value>
<value>Q4H</value>
<value>Q6H</value>
<value>Q8H</value>
<value>ONCE</value>
<value>NOW</value>
<value>Q1H</value>
<value>Q2H</value>
<value>Q12H</value>
<value>DAILY</value>
</frequency><instruction><value>DAY 0. Administer immediately prior to transplant if necessary.</value>
<value>DAY 1.  Administer pre-chemotherapy as required. May be administered by the sublingual route.</value>
<value>DAY 8.  Administer pre-chemotherapy as required. May be administered by the sublingual route.</value>
<value>DAY 15.  Administer pre-chemotherapy as required. May be administered by the sublingual route.</value>
<value>DAY 22.  Administer pre-chemotherapy as required. May be administered by the sublingual route.</value>
<value>DAY 1 of 21.  Administer pre-chemotherapy as required. May be administered by the sublingual route.</value>
<value>DAY 8 of 21.  Administer pre-chemotherapy as required. May be administered by the sublingual route.</value>
<value>DAY 1 of 21.  Administer pre-CARBOplatin as required. May be administered by the sublingual route.</value>
<value>DAYS 1, 2 &amp; 3 of 21.  Administer pre-chemotherapy as required. May be administered by the sublingual route.</value>
<value>DAY 1 of 28.  Administer pre-chemotherapy as required. May be administered by the sublingual route.</value>
<value>DAYS 2, 3, 4 &amp; 5 of 28.  Administer pre-chemotherapy as required. May be administered by the sublingual route.</value>
<value>DAY 8 of 28.  Administer pre-chemotherapy as required. May be administered by the sublingual route.</value>
<value>DAY 1 of 21.  Administer as required. May be administered by the sublingual route.</value>
<value>DAY 1.  Administer pre-chemotherapy as required. May be administered by the PO route.</value>
<value>DAY 8.  Administer pre-chemotherapy as required. May be administered by the PO route.</value>
<value>DAY 15.  Administer pre-chemotherapy as required. May be administered by the PO route.</value>
<value>DAY 22.  Administer pre-chemotherapy as required. May be administered by the PO route.</value>
<value>DAY 1 of 21.  Administer pre-chemotherapy as required. May be administered by the PO route.</value>
<value>DAY 8 of 21.  Administer pre-chemotherapy as required. May be administered by the PO route.</value>
<value>DAY 1 of 21.  Administer pre-CARBOplatin as required. May be administered by the PO route.</value>
<value>DAYS 1, 2 &amp; 3 of 21.  Administer pre-chemotherapy as required. May be administered by the PO route.</value>
<value>DAY 1 of 28.  Administer pre-chemotherapy as required. May be administered by the PO route.</value>
<value>DAYS 2, 3, 4 &amp; 5 of 28.  Administer pre-chemotherapy as required. May be administered by the PO route.</value>
<value>DAY 8 of 28.  Administer pre-chemotherapy as required. May be administered by the PO route.</value>
<value>DAY 1 of 21.</value>
<value>DAY 1 of 21.  Administer as required. May be administered by the PO route.</value>
<value>DAY 1 of 21.  Administer pre-chemotherapy, as required. </value>
</instruction><volume></volume><units><value>mg</value>
</units><additionalnotes></additionalnotes><population><value>Adjuvant Vinorelbine/CISplatin (every 28 days). Non-Small Cell Lung Cancer</value>
<value>Adjuvant Vinorelbine/CISplatin (every 21 days). Non-Small Cell Lung Cancer</value>
<value>Vinorelbine / CISplatin. Advanced NSCLC</value>
<value>Vinorelbine / CARBOplatin. Non-Small Cell Lung Cancer (Advanced Stage)</value>
<value>CISplatin &amp; Vinorelbine with CONCURRENT RT. Non-Small Cell Lung Cancer</value>
<value>Gemcitabine / CARBOplatin. Non-Small Cell Lung Cancer</value>
<value>Gemcitabine / CISplatin. Non-Small Cell Lung Cancer</value>
<value>cyclophosphamide, DOXOrubicin, vinCRIStine (CAV). Small Cell Lung Cancer.</value>
<value>CISplatin/etoposide (po). Small Cell Lung Cancer</value>
<value>CISplatin/etoposide (IV). Small Cell Lung Cancer.</value>
<value>Carboplatin/Etoposide (IV). Small Cell Lung Cancer.</value>
<value>CARBOplatin/Etoposide (IV/po). Small Cell Lung Cancer</value>
<value>Etoposide (Days 1-5)/CISplatin (Days 1 &amp; 8) with concurrent RT. Pancoast Tumor</value>
<value>Vinorelbine and CARBOplatin with CONCURRENT RT. Non-Small Cell Lung Cancer.</value>
<value>DOXOrubicin/CISplatin/cyclophosphamide (PAC). Thymic Malignancy</value>
<value>CISplatin/DOXOrubicin/vinCRIStine/cyclophosphamide. Thymoma</value>
</population><indicationprn></indicationprn><backgroundinformation></backgroundinformation><prninformation><value>YES</value>
</prninformation><ahsformularystatus><value>Formulary.</value>
</ahsformularystatus><ahfsname><value>Anxiolytics, Sedatives, and Hypnotics, Benzodiazepines</value>
</ahfsname><highalert></highalert><maximumprndose></maximumprndose><din><value>02041456</value>
<value>02041464</value>
<value>02041472</value>
</din></drug>